Buy Acer Therapeutics Stock | OPXA Stock Price & Latest News | Public.com
OPXA

Acer Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Acer Therapeutics (OPXA) stock trends here

    About OPXA

    Acer Therapeutics, Inc. is a pharmaceutical company. It engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes ACER-001 Edsivo and ACER-2820. The Edsivo is a type of celiprolol for Vascular Ehlers-Danl...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$38,92M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.84
    1 Year Low$2.15
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app